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Non-invasive imaging of biological processes in vivo is invaluable in advancing biology. Photoacoustic
tomography is a scalable imaging technique that provides higher resolution at greater depths in tissue than
achievable by purely optical methods. Here we report the application of two spectrally distinct near-infrared
fluorescent proteins, iRFP670 and iRFP720, engineered from bacterial phytochromes, as photoacoustic
contrast agents. iRFPs provide tissue-specific contrast without the need for delivery of any additional
substances. Compared to conventional GFP-like red-shifted fluorescent proteins, iRFP670 and iRFP720
demonstrate stronger photoacoustic signals at longer wavelengths, and can be spectrally resolved from each
other and hemoglobin.We simultaneously visualized two differently labeled tumors, one with iRFP670 and
the other with iRFP720, as well as blood vessels. We acquired images of a mouse as 2D sections of a whole
animal, and as localized 3D volumetric images with high contrast and sub-millimeter resolution at depths
up to 8 mm. Our results suggest iRFPs are genetically-encoded probes of choice for simultaneous
photoacoustic imaging of several tissues or processes in vivo.
P
hotoacoustic (PA) tomography is an emerging technology that can produce images of living objects at
multiple scales, ranging from organelles to organs1. In contrast to purely optical methods2, such as fluor-
escence imaging and bioluminescence imaging, photoacoustic tomography (PAT) can achieve good spatial
resolution at depths of more than 1 mm inside scattering biological tissue1,3. Based on the photoacoustic effect,
PAT detects thermoelastically induced ultrasonic waves as a result of light absorption by biomolecules. Ultrasonic
waves are scattered much less than photons in tissue. This enables PAT to be used for high resolution imaging
deep in tissue. In PAT, the spatial resolution scales with the imaging depth depending on the application, while
still maintaining a high depth-to-resolution ratio4. Various endogenous and exogenous absorbers can serve as
PAT contrast agents, enabling the visualization of vasculature, blood oxygenation levels, biomarkers and gene
expression3. The primary endogenous absorbers are DNA/RNA, hemoglobin, melanin, water, and lipid.
Exogenous contrast agents including organic dyes, nanoparticles, and reporter genes, extend the applications
of PAT to molecular imaging.
The application of genetically encoded contrast agents in PAT is a powerful approach for in vivo deep-tissue
monitoring of specific genetically defined cell populations with good spatial resolution5. Compared with dyes and
nanoparticles, genetically encoded probes have several advantages. First, the labeling is specific to the transfected
cell population. Second, reporter genes avoid some difficulties associated with targeted delivery, particularly non-
specific accumulation and clearance from the body. Strong light absorbing fluorescent proteins (FPs)6,7 with low
andmoderate quantum yields provide excellent contrast for PAT3. EGFP, DsRed, andmCherry have been applied
to imaging of small transparent organisms such as zebrafish and fruit fly pupa8. For deep-tissue PAT, probes
absorbing in the near-infrared (NIR) spectral range are desirable. In the NIR optical window of 650–900 nm,
absorption by hemoglobin and water is low, making probes absorbing within this range particularly useful9.
Although several far-red GFP-like FPs such as mNeptune10, E2-Crimson11, eqFP67012, TagRFP65713 and
TagRFP67514 have been available, and their utility for in vivo imaging was demonstrated, their absorption was
not in the NIR optical window7. Bacterial phytochromes are promising templates to engineer NIR FPs, NIR
reporters15 and NIR optogenetic tools16. One NIR FP of this type, called iRFP713 (aka iRFP)17, was visualized by
using PAT in mice18. iRFP713 was also used as a contrast agent for non-invasive detection of in vivo circulating
tumor cells by a combined PA and fluorescence flow cytometry approach19.
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Imaging multiple contrast agents in PAT can provide essential
information about complex physiological and pathogenic processes
in living organisms, such as the interaction of a tumor with its
microenvironment. At least two different NIR genetically encoded
probes are required for imaging more than one specifically defined
cell population inside living mammals. Until now, spectrally distinct
NIR FPs designed for this purpose have not been available.
Additionally, the simultaneous imaging of multiple genetically
encoded contrast agents has never before been demonstrated with
PAT. Recently developed iRFP670 (absorption/emission maxima at
645 nm/670 nm)20 and iRFP720 (absorption/emission maxima at
703 nm/720 nm)20 FPs, engineered on the basis of two different
bacterial phytochromes, are good candidates for multicontrast
PAT. These proteins have high affinity for and incorporate endogen-
ous biliverdin, which is abundant in mammalian tissues, as a chro-
mophore. As they do not require any exogenous supplements to be
added, these FPs can be used as easily as conventional GFP-like FPs.
Expression of these proteins and closely related iRFP713 in different
types ofmammalian cells and tissues, such as various human cells, rat
cells, mouse liver and mouse spleen, have been reported10,13. Both
iRFP670 and iRFP720 proteins have high extinction coefficients and
relatively low fluorescence quantum yields (Table 1), which are
favorable properties of PA contrast agents, as PA signals are propor-
tional to the product of the molar extinction coefficient and the
nonradiative quantum yield3. Because the two iRFPs are spectrally
distinct and both absorb in the NIR optical window (Figure 1a), we
can separate the contribution to the signal of each iRFP from that of
each other and of hemoglobin.
Results
Characterization of iRFP670 and iRFP720 as probes formulticon-
trast PAT. To verify that iRFP670 and iRFP720 are indeed the best
available candidates for simultaneous deep-tissue imaging in PAT,
we compared PA signals of purified iRFP670, iRFP720, iRFP713, and
other available far-red shifted fluorescent proteins including
mNeptune, E2-Crimson and eqFP670 (Table 1). Hemoglobin from
lysed blood was used as the reference standard. The purified FPs
diluted to equal concentrations were imaged using a PA computed
tomography (PACT) setup21 (Figure 1b) at four different laser
wavelengths spanning the spectral region of the FPs’ absorption
(600 nm, 645 nm, 680 nm and 715 nm). The amplitudes of the
PACT signals from FPs were normalized to the signal from blood
at 600 nm. The values (Figure 1c) show that all FPs engineered from
bacterial phytochromes (iRFP670, iRFP713 and iRFP720), with
absorption maxima in the NIR optical window, produced signals
more than 2-fold higher than blood at wavelengths above 600 nm.
These protein’s favorable spectra make them more suitable for
simultaneous detection with hemoglobin than the other tested far-
red FPs. Figure 1c also demonstrates that two wavelengths, 645 nm
and 715 nm, can be used to separate the signals of iRFP670 and
iRFP720, from each other and from the blood signal. At 645 nm,
the signal of iRFP670 is nearly twice that of iRFP720, whereas at
715 nm, the signal of iRFP670 is almost negligible. This corresponds
well with the spectral overlay. To estimate the contrast between
proteins, we quantified the ratios of the signals of pairs of FPs at
two wavelengths. The ratio between iRFP670 and iRFP720 signals at
645 nm and 715 nm is 11-fold, while for iRFP713 and iRFP720
at these wavelengths it is 4.3-fold, and for iRFP670 and iRFP713 at
645 nm and 680 nm it equals to 2.9-fold. These data support the
choice of iRFP670 and iRFP720 for multicontrast PAT.
From the above discussion, four wavelengths (645 nm, 715 nm,
750 nm and 800 nm) were selected for multicontrast PA imaging of
iRFP670 and iRFP720, and hemoglobin; the first two wavelengths
correspond to the absorption peaks of iRFP670 and iRFP720.
750 nm and 800 nm were chosen due to the negligible absorption
from the proteins while relatively high hemoglobin absorption was
maintained. This combination enabled separate detection of two FPs,
and hemoglobin-form lysed blood, not only on the surface but also at
depths up to 1.9 cm of chicken breast tissue (Figure 1d). The con-
tribution by each absorber to the signal was estimated using a least
squares algorithm. In this method, the signal is modeled as a linear
combination of signals from each absorber, and the weight of each
absorber to the signal is determined by its molar extinction coef-
ficient. The intrinsic advantage of the PACT’s setup to penetrate
deep in tissue1, combined with the NIR-shifted absorption, allowed
detection at such a depth. Due to the differences in illumination
schemes between the in vitro and in vivo experiments, the noise
equivalent concentration (NEC) was not calculated for this system
as the sensitivity is correlated with the illumination intensity.
However, the in vitro results show that despite strong attenuation
of the illumination, the proteins are still separable spectrally from
each other and from blood.
Next we estimated the applicability of iRFP670 and iRFP720 in a
deep PA macroscopy (deep-PAMac) imaging setup22. Compared
with PACT, deep-PAMac (which is an acoustic-resolution PAT
implementation) images less deeply but can produce a depth-
resolved top-down cross-section, which can then be raster scanned
to produce a volumetric image. Figure 2a is a schematic of the setup.
Compared to whole-body PACT, deep-PAMac has the additional
advantage of allowing the stacking of tissue to simulate depth while
maintaining the same geometry. To test the applicability of the iRFPs
for multicontrast deep-PAMac, we imaged protein samples of
iRFP670, iRFP720, and whole blood, without and with a tissue
overlay of 5.0 mm to simulate depth (Figure 2b). To analyze the
sensitivity of the iRFPs’ detection deep in tissue, we calculated the
NECs. For both proteins the NEC values at the optimal excitation
wavelengths (645 nm for iRFP670 and 715 nm for iRFP720) were
more than one order of magnitude lower than for the blood
(Figure 2c). We estimated the ratio of signals between iRFP670
and iRFP720 at 645 nm and 715 nm to be 10-fold, close to what
we observed in PACT. Also as in PACT, the proteins (32 mMof each
FP) and the blood (2.3 mM concentration of hemoglobin) could be
separated using the four wavelengths (Figure 2b).
Application of iRFP670 and iRFP720 to in vivo PAT. After the in
vitro experiments, we tested the performance of iRFP670 and iRFP720
in simultaneous deep-tissue imaging in vivo. We employed a mouse
xenograft breast cancer model23. As contrast agents, FPs allow for
Table 1 | Optical properties of the far-red and near-infrared fluorescent proteins used in the study
FPs
Absorption
maximum (nm)
Excitation
maximum (nm)
Emission
maximum (nm)
Molar extinction
coefficient (M21 cm21)
Quantum yield of
fluorescence
Molar extinction coefficient3 Non-
radiative quantum yield (M21 cm21)
mNeptune 600 600 650 59,000 0.20 47,200
E2-Crimson 603 605 646 58,500 0.12 51,480
eqFP670 603 605 670 70,000 0.06 65,800
iRFP713 692 690 713 98,000 0.06 92,120
iRFP670 645 643 670 114,000 0.11 101,460
iRFP720 703 702 720 96,000 0.06 90,240
www.nature.com/scientificreports
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analysis of labeled cells and tissues by conventional fluorescent
techniques, such as microscopy, flow cytometry, and whole-body
imaging. To select for stably expressing rat adenocarcinoma MTLn3
cells for tumor implantation, preclonal mixtures were selected by
fluorescence activated cell sorting (FACS). The selected cells
expressing iRFP670 and iRFP720 were analyzed by microscopy
(Figure 3a), and are distinguishable from each other by flow
cytometry (Figure 3b). To demonstrate that iRFP670 and iRFP720
can be used simultaneously and separated from blood signal in vivo,
mice were co-injected with two types of MTLn3 cells (expressing either
iRFP670 or iRFP720) causing two tumors to grow spatially close to
each other. Three weeks after the injection, the tumors were easily
separated from each other by whole-body epifluorescence imaging in
two filter channels, using a standard IVIS Spectrum imaging system
(Figure 3c).
At the same time, we imaged the mice with the two tumors by
PACT. The circular-array PACT shown schematically in Figure 1b is
designed to accommodate cylindrical objects, such as the mouse
trunk24. The extensive imaging depth of this setup provides 2D
cross-sections of a whole mouse body with 0.1 mm in-plane resolu-
tion18. A representative mouse with the two implanted tumors
(Figure 4a) was imaged at all four wavelengths (Figure 4b). The
combined image with unmixed signals overlaid (Figure 4c) shows
both the iRFP670 and iRFP720 expressing tumors and major blood
vessels in a cross-section of the mouse body (see also Supplementary
Figures S1 and S2 online).
Further, we applied the deep-PAMac setup to the same mice to
study the tumors in more detail. The deep-PAMac, utilized with a
10 MHz center frequency focused transducer, can achieve good
resolution (280 mm lateral, 75 mm axial) at depths up to a few milli-
meters and, due to the setup geometry, gain the ability to simulate
depth by overlaying additional biological tissue on the sample18,25.
The results show detailed images of the tumors and surrounding
vessels at depths of up to 8 mm inside the mouse body (Figure 5a).
Two orthogonal maximum amplitude projection images per each of
four wavelengths show different spectral dependence of the signals
from the tumors and from the surrounding tissue, thus allowing
spectral separation. The spatial locations of the two tumors and
blood are detectable even at depths up to 5 mm under overlaid
biological tissue (Figure 5b). Although the signal to noise ratio is
low, the spectral differences between the absorbers allowed discrim-
inating between regions. The wavelength dependent attenuation of
the incident light can lead to inaccuracies in the quantitative values
obtained; however, the spectra of the absorbers are different enough
to discriminate the locations of the absorbers. This demonstrates the
ability to separate image contributions of iRFP670, iRFP720, and
hemoglobin noninvasively in one subject (combined pseudocolor
images in Figure 5). The differences in a scale between the proteins
could be due to variation in expression.We quantified the PA signals
from tumors and blood and estimated the concentration of the iRFPs
to be between 16–30 mM.
Discussion
PAT is a promising technique for visualizing biological processes deep
inside tissues. In this paper we demonstrated that PAT can be utilized
to simultaneously and noninvasively image two differently labeled
tumors and blood vessels in vivo. This is the first demonstration of
Figure 1 | Photoacoustic properties of purified iRFP670 and iRFP720 proteins. (a) Overlay of the molar extinction spectra of iRFP670, iRFP720,
oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (Hb). (b) Illumination and detection scheme for PACT. (c) Photoacoustic signal
amplitudes of equal amounts of purified FPs (mNeptune, E2-Crimson, eqRFP670, iRFP670, iRFP713, iRFP720) at the four indicated wavelengths. Lysed
bovine blood was used as a reference standard. The values were normalized to blood signal at 600 nm. (d) PACT images of tubes containing lysed blood
and equal concentrations of purified iRFP670 and iRFP720. Total hemoglobin (HbT) (in red), iRFP670 (in green) and iRFP720 (in blue) signals were
detected and unmixed at different depths (0, 0.9 and 1.9 mm) of overlaid tissue. Scale bar, 1 mm.
www.nature.com/scientificreports
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PAT with two NIR genetically encoded probes and hemoglobin as the
contrast agents in a living mouse.
We showed that, due to the NIR shifted spectra and sufficient
spectral difference from each other, iRFP670 and iRFP720 are more
suitable probes for in vivo PAT than conventional far-red GFP-like
FPs. Use of GFP-like FPs for PA imaging of mammals is hindered by
high hemoglobin absorption at wavelengths below 650 nm. In addi-
tion, chromophore formation in GFP-like FPs is oxygen-dependent.
Since many tumors and pathogenic tissues are hypoxic, iRFP670 and
iRFP720 are advantageous because the formation of their chromo-
phores does not require oxygen. Furthermore, the NIR FPs exhibit
good photoacoustic properties because of their high extinction coef-
ficients and low fluorescence quantum yields, resulting in effective
thermal relaxation and strong PA signals. Additionally, iRFP670 and
iRFP720 have shown good photostability, which allows multiple
optical exposures without altering the optical properties13.
Genetically encoded iRFP670 and iRFP720 are produced by living
cells and tissues, eliminating the need for delivery of contrast reagents
Figure 2 | Deep-PAMac characterization of iRFP670 and iRFP720 proteins in phantom. (a) Illumination and detection scheme for deep-PAMac. (b)
Deep-PAMac cross-sections of the tubes containing whole blood (left, in red), iRFP720 (center, in blue) and iRFP670 (right, in green) at the four
indicated wavelengths, without (left panel) andwith (right panel) the overlaid tissue of 5 mmwidth. Dashed lines indicate the tube boundaries. Spectrally
unmixed images of blood (HbT, in red), iRFP670 (in green) and iRFP720 (in blue) are shown at the bottom. (c) Calculated noise equivalent
concentrations (NECs) for each of the purified proteins and total hemoglobin from blood at two depths (0 and 5 mm) mimicked by the tissue overlay.
Scale bar, 1 mm.
Figure 3 | Fluorescence imaging ofMTLn3 cells in culture and in xenograft tumors. (a)Wide-field fluorescencemicroscopy ofMTLn3 adenocarcinoma
cells stably expressing iRFP670 or iRFP720. The filter combinations used were: 605/40 nm excitation and 640 long-pass for imaging of iRFP670, and 665/
45 nm excitation and 725/50 nm emission for iRFP720. Scale bars, 10 mm. (b) Flow cytometry analysis ofMTLn3 cells shown in (a). Cell fluorescence was
excited with 635 nm laser and detected with a combination of two indicated emission filters. 10,000 events were analyzed for each cell type. (c)
Representative fluorescence images of a living mouse with two tumors each expressing either iRFP670 (top tumor) or iRFP720 (bottom tumor). The
images show the two channels with optimal fluorescence filters for iRFP670 (excitation 640/30 nm and emission 680/20 nm) and for iRFP720 (excitation
710/30 nm and emission 760/20 nm) and their overlay shown on the right. The images were obtained three weeks after cell injections. The color bars
indicate the total fluorescent radiant efficiency in [p/s/cm2/sr]/[mW/cm2].
www.nature.com/scientificreports
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Figure 4 | PACT imaging of iRFP670 and iRFP720 in mouse tumor xenograft model. (a) Photograph of the mouse with iRFP670 (green circle) and
iRFP720 (blue circle) expressing tumors growing in the mammary pads, three weeks after cell injection. The yellow line shows the approximate region of
the imaged cross-section. The tumor regions are circled in blue and green. (b) PACT images of a mouse cross-section shown in (a) at four indicated
wavelengths. (c) Spectrally separated image in pseudocolors (iRFP670 in green, iRFP720 in blue, total hemoglobin in red). The signals were normalized to
the spectrally separated signal for blood. Dashed yellow and black lines show the mouse body borders. Scale bar, 1 mm.
Figure 5 | Deep-PAMac imaging of iRFP670 and iRFP720 in mouse tumor xenograft model. Deep-PAMac maximum amplitude projection images of
the tumors and surrounding major blood vessels taken with no overlaid tissue (a, b) and with 5 mm overlaid tissue (c, d) three weeks after cell injection.
The four left images in panels (a, c) were acquired at the four indicated wavelengths. The pseudocolored images in panels (b, d) correspond to maximum
amplitude projections with orthogonal orientations. The volumetric spectrally separated signals (iRFP670 in green, iRFP720 in blue, total
hemoglobin in red) were normalized to the spectrally separated signal for blood. Positions of the tumors are indicated by the gray arrows.
www.nature.com/scientificreports
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such as organic dyes or nanoparticles. This property is advantageous
for chronic monitoring of processes on a prolonged time scale.
Moreover, the NIR FPs can be detected using conventional fluor-
escence modalities, which are easily accessible and provide additional
information. Fluorescence in vivo imaging techniques, such as whole-
body planar imaging and fluorescence molecular tomography
(FMT)26, complement PAT because they allow higher detection sens-
itivity, although at lower resolution than PAT. Lastly, iRFP670 and
iRFP720 fluorescence allows additional postmortem detection of
individual cells in histological sections or by using flow cytometry.
We took advantage of the scalability of PAT in different imple-
mentations and visualized iRFP670 and iRFP720 expressing tumors
and hemoglobin at two scales. First, we imaged whole-mouse 2D
sections with PACT, and second, we performed localized volumetric
imaging of tumors inside the mouse body with deep-PAMac. The
deep-PAMac approach provided both spectral resolution and max-
imum amplitude projections in three orthogonal planes. This com-
bination resulted in spectrally resolved volumetric images, even at a
depth of 5 mm, as mimicked by the overlaid tissue. Although photo-
acoustic imaging of single cells expressing FPs was demonstrated in
cell culture27, such a high sensitivity has not been shown in in vivo
experiments. Using the presented setup, we were able to detect
tumors of a millimeter size and larger inside of a living animal.
Further optimization of the system’s geometry and imaging setup
will allow reaching the higher sensitivity in vivo, where the back-
ground absorption from blood and the intervening tissue between
the absorbing cells and the surface of the body interfere with the
detection.
In conclusion, multiple genetically-encoded contrast agents, such
as iRFP670 and iRFP720 separated from hemoglobin, were imaged
simultaneously deep in vivo using PAT. The future development and
integration of various photoacoustic imaging approaches will ad-
vance studies of complex physiological and pathogenic processes
for prolonged time periods in living animals atmolecular and cellular
levels. The presented technique holds great potential for both bio-
logical and preclinical studies on model organisms like mice.
Although not applicable to humans, current progress in gene transfer
technology23 makes it possible to specifically label a variety of cells
and organs in vivo in model animals. As compared to other optical
methods, for example epifluorescence imaging, photoacoustic tomo-
graphy achieves higher absorption-based contrast and visualizes
more details because ultrasonic waves are scattered less than photons
in tissue. Moreover, it provides additional information due to its
ability to detect endogenous contrast agents, such as hemoglobin
from blood. Multicontrast PAT, as the technique incorporating dis-
tinct NIR FPs demonstrated here, can be further applied to non-
invasive detection of several processes including cancer growth,
organ development, spread of infection, drug responses and gene
activities in a living animal.
Methods
Protein expression and purification. Bacterial plasmids encoding mNeptune, E2-
Crimson and eqFP670 with polyhistidine tags were provided by B. Glick (University
of Chicago, USA), M. Lin (Stanford University, USA), and K. Lukyanov (Institute of
Bioorganic Chemistry, Russia). Recombinant GFP-like FPs were expressed in
LMG194 bacterial cells grown in RM medium supplemented with ampicillin,
kanamycin, and 0.002% arabinose and then purified using a Ni-NTA agarose
(Qiagen) according to the manufacture’s protocol.
The iRFP670, iRFP713, and iRFP720 with polyhistidine tags on the N-terminus
were expressed in LMG194 bacterial cells co-expressing heme oxygenase grown in
RM medium supplemented with ampicillin, kanamycin, 0.002% arabinose, and
0.02% rhamnose. The NIR iRFPs were purified using Ni-NTA agarose and then
washed in a buffer where imidazole was substituted for EDTA. All purified FP
solutions were diluted to equal concentrations of 32 mM.
Photoacoustic studies of purified proteins. To determine the best FP for PA
imaging, we constructed two phantoms consisting of approximately 40 mm long,
0.30 mm inner diameter (i.d.) tubing sections (Silastic) filled with one of the FP
samples or lysed bovine blood. The tubes were then glued in parallel onto a flat gelatin
block and imaged at 600 nm, 645 nm, 680 nm, and 715 nm, with approximately
90 mJ incident energy for the three lower wavelengths and 30 mJ incident energy at
715 nm. A 512-element ring transducer PACT system with top illumination from
either an OPO laser (Vibrant 335I) or a Ti-Sapphite laser (LT-2211A) was used21.
Both lasers were needed to cover the desired wavelength range. The wavelengths were
chosen to cover wavelengths near the peak excitation of each of the FPs. The signal
amplitude was corrected for laser energy at each wavelength using the average power
reading from a power meter for normalization, and the signal from each of the FPs
was further normalized to the signal of blood at 600 nm for comparison.
The depth analysis was performed on two phantoms consisting of approximately
15 mm long, 1.47 mm inner diameter tubing sections (Silastic) filled with iRFP670,
iRFP720, or blood (lysed or whole) for comparison. The sections were then embedded
in chicken breast tissue or glued onto a gelatin block and imaged using either the
PACT or deep-PAMac setups, with illumination provided by the OPOor Ti-Sapphire
laser28. Additional depths were simulated by stacking sections of chicken breast tissue
on the sample surface. Twenty B-mode images were averaged at each depth. The noise
equivalent concentration for each sample was calculated by dividing the known
concentration of the absorber (32 mM for each FP and 2.3 mM for hemoglobin in the
blood) by the signal-to-noise ratio in the region of the sample, and provided an
estimate of the expected minimum concentration detectable by each system for this
target.
Mammalian plasmids and cell culture.The plasmids used for expression of iRFP670
and iRFP720 in mammalian cells were based on pEGFP-N1 backbone (Clontech).
The iRFP670 and iRFP720 genes were PCR-amplified as AgeI-NotI fragments and
swapped with the EGFP gene in pEGFP-N1 vector, thus generating the piRFP670 and
piRFP720 plasmids.
A rat adenocarcinoma MTLn3 cell line was grown in aMEM medium (Life
Technologies) containing 5% fetal bovine serum, 0.5% penicillin-streptomycin, and
2 mM glutamine. Plasmid transfections were performed using an Effectene reagent
(Qiagen) according to the manufacturer’s protocol. Stably expressing preclonal cell
mixtures were selected with 700 mg/ml G418 antibiotic. Sorting of fluorescent cells
was performed using a MoFlo XDP sorter (Beckman Coulter) equipped with a
676 nm Kr laser and a 700 nm long-pass emission filter.
Fluorescence imaging and flow cytometry. For fluorescence microscopy, cells were
cultured in 35 mm glass bottom culture dishes with no. 1 cover glasses (MatTek). The
MTLn3 cells expressing either iRFP670 or iRFP720 were imaged using an Olympus
IX81 inverted epifluorescence microscope equipped with 200 W Me-Ha arc lamp
(Lumen220Pro, Prior), a 1003 1.4 numerical aperture oil immersion objective lens
(UPlanSApo, Olympus), and two filter sets (one a 605/40 nm excitation, 667/30 nm
emission and the other a 682/12 nm excitation, 721/42 nm emission). All filter sets
were from Chroma. SlideBook v.4.1 software (Intelligent Imaging Innovations) was
used to operate Olympus IX81 inverted microscope. Unmixed channels were
pseudocolored and overlaid using the SlideBook v.4.1.
Discrimination between the two types of MTLn3 cells stably expressing iRFP670
and iRFP720 (one FP type per cell) was performed using a LSRII cytometer (BD
Biosciences) equipped with a 635 nm laser and 660/20 nm and 710/20 nm emission
filters. The obtained dot plots were superimposed. Flow cytometry calculations were
performed using FlowJo software (Tree Star).
To implant xenograph tumors, approximately 106 MTLn3 cells stably expressing
either iRFP670 or iRFP720 were injected into the mammary glands of female, 5–7
weeks old, SCID/NCr mice (Taconic), and imaged 3 weeks later using the IVIS
Spectrum system (PerkinElmer/Caliper) in epifluorescence mode. Belly fur was
removed using a depilatory cream. Mice were fed with AIN-93M Maintenance
Purified Diet (TestDiet) to reduce their intrinsic autofluorescence level. All quant-
itative measurements of fluorescence signals were performed using Living Image v.
4.3.1 software (PerkinElmer/Caliper). To remove bleed-through of the excitation
light into the emission channel, the software encoded adaptive background sub-
traction was performed.
Photoacoustic studies inmouse tumor xenograft model. For both PACT and deep-
PAMac, approximately 106MTLn3 cells stably expressing either iRFP670 or iRFP720
were injected into themammary glands of four SCID/NCrmice. Three out of the four
mice developed tumors which were photoacoustically detected two weeks later using
PACT. For PACT, mice were imaged at the tumor region using four wavelengths,
645 nm, 715 nm, 750 nm, and 800 nm. For spectral separation, the images were then
processed using a linear least-squares method for the four absorbers8. Themodel used
is as follows:
PA~eC,
where e is a matrix of the extinction coefficients of each of the absorbers at each of the
wavelengths, PA contains all the measurements per pixel at each wavelength, and C is
the concentration of each absorber at each pixel. In this model we assume proper
compensation for the incident light; however, for deeper imaging, the incident light
attenuation is wavelength dependent and can lead to quantitative errors.We solve for
C using a least squares solution:
eT e
 {1
eTPA~C
The result is in relative values due to the unknown attenuation of light with depth.
www.nature.com/scientificreports
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For clear separation from blood, the wavelengths were chosen so that at least one
wavelength was near the maximum absorption of each of the iRFP proteins, and light
at other wavelengths was weakly absorbed.
For deep-PAMac, a 20 mm by 14 mm area was imaged. Images were taken at the
same NIR wavelengths as in the PACT experiment, with depth simulated by stacking
approximately 5 mmof chicken breast tissue over the sample. The same least-squares
method was performed for spectral separation at both depths. To assess the iRFP670
and iRFP720 concentrations, we assumed the average total hemoglobin concentra-
tion to be similar through the depths imaged, and we normalized the calculated
concentrations of iRFP670 and iRFP720 to the average total hemoglobin concen-
tration at each depth. As noted previously, wavelength dependent attenuation of the
incident light can lead to inaccuracies in the estimation of the concentration.
Assuming that the illumination is similar per depth for the nearby blood vessels, and
that the total hemoglobin concentration is 2.3 mM, we calibrate each of the proteins
signal to the total hemoglobin signal at each depth. Consequently, the maximum
iRFP670 and iRFP720 concentrations were estimated to be 16–30 mM.
All animal experiments were performed in AAALAC approved facilities using
protocols approved either by the Albert Einstein College of Medicine Animal Usage
Committee (fluorescence imaging) or by the Washington University in St. Louis
Animal Use Committee (photoacoustic imaging).
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